Three posters being presented at the Society for Maternal-Fetal Medicine 44th Annual Pregnancy Meeting examined the impact of continuous glucose monitoring on pregnancy outcomes.
Diabetes in pregnancy is known to put both the mother and child at-risk for numerous negative health outcomes, such as preterm delivery, birthweight extremes, congenital anomaly, stillbirth, admission to neonatal intensive care units, and even neonatal death.1 With 16% of pregnancies globally being impacted by pre-existing or gestational diabetes, managing the condition during pregnancy is essential.2
Continuous glucose monitors (CGM) have become an essential tool in monitoring diabetes, and can likely have a positive impact on disease management during pregnancy. Three posters being presented at the Society for Maternal-Fetal Medicine 44th Annual Pregnancy Meeting examined the role CGM plays in pregnancy.
Community Pharmacist-Led CGM Programs Can Boost Clinic Revenue While Helping Patients
April 12th 2024Although over 38 million people in the US have diabetes, continuous glucose monitor (CGM) uptake is low. Community pharmacists are uniquely positioned to promote uptake due to their frequent interactions with patients and expertise in chronic condition counseling.